These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10428923)

  • 1. Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.
    Tarantino PM; Zhi C; Wright GE; Brown NC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1982-7. PubMed ID: 10428923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.
    Daly JS; Giehl TJ; Brown NC; Zhi C; Wright GE; Ellison RT
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2217-21. PubMed ID: 10898708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.
    Kuhl A; Svenstrup N; Ladel C; Otteneder M; Binas A; Schiffer G; Brands M; Lampe T; Ziegelbauer K; Rübsamen-Waigmann H; Haebich D; Ehlert K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):987-95. PubMed ID: 15728893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3.
    Tarantino PM; Zhi C; Gambino JJ; Wright GE; Brown NC
    J Med Chem; 1999 Jun; 42(11):2035-40. PubMed ID: 10354411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.
    Zhi C; Long ZY; Gambino J; Xu WC; Brown NC; Barnes M; Butler M; LaMarr W; Wright GE
    J Med Chem; 2003 Jun; 46(13):2731-9. PubMed ID: 12801236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved synthesis of antibacterial 3-substituted 6-anilinouracils.
    Svenstrup N; Kuhl A; Ehlert K; Häbich D
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3215-8. PubMed ID: 18468893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils.
    Zhi C; Long ZY; Manikowski A; Brown NC; Tarantino PM; Holm K; Dix EJ; Wright GE; Foster KA; Butler MM; LaMarr WA; Skow DJ; Motorina I; Lamothe S; Storer R
    J Med Chem; 2005 Nov; 48(22):7063-74. PubMed ID: 16250666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III: design, synthesis, and biological evaluation.
    Ali A; Taylor GE; Ellsworth K; Harris G; Painter R; Silver LL; Young K
    J Med Chem; 2003 May; 46(10):1824-30. PubMed ID: 12723946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
    Zhi C; Long ZY; Manikowski A; Comstock J; Xu WC; Brown NC; Tarantino PM; Holm KA; Dix EJ; Wright GE; Barnes MH; Butler MM; Foster KA; LaMarr WA; Bachand B; Bethell R; Cadilhac C; Charron S; Lamothe S; Motorina I; Storer R
    J Med Chem; 2006 Feb; 49(4):1455-65. PubMed ID: 16480282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
    Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
    J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.
    Xu WC; Wright GE; Brown NC; Long ZY; Zhi CX; Dvoskin S; Gambino JJ; Barnes MH; Butler MM
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4197-202. PubMed ID: 21684746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III.
    Ali A; Aster SD; Graham DW; Patel GF; Taylor GE; Tolman RL; Painter RE; Silver LL; Young K; Ellsworth K; Geissler W; Harris GS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2185-8. PubMed ID: 11514166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site directed inhibitors of replication-specific bacterial DNA polymerases.
    Wright GE; Brown NC; Xu WC; Long ZY; Zhi C; Gambino JJ; Barnes MH; Butler MM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):729-32. PubMed ID: 15664846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils.
    Brown NC; Gambino J; Wright GE
    J Med Chem; 1977 Sep; 20(9):1186-9. PubMed ID: 411934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.
    Wright GE; Brown NC
    J Med Chem; 1980 Jan; 23(1):34-8. PubMed ID: 6767030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.